DNMT1 gene copy number does not influence susceptibility to development of malignant lymphoproliferative disease

Anticancer Research

Volumn 22, Issue 6 A, 2002, Pages 3405-3407

  Franchina, Maria ^a   Kay, Peter H ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

DNA methylation; DNMT1; Gene copy number; Neoplastic transformation

Indexed keywords

GENE PRODUCT; PROTEIN DNMT1; UNCLASSIFIED DRUG;

ALLELISM; ARTICLE; CELL TRANSFORMATION; CLINICAL ARTICLE; DENSITOMETRY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DNA METHYLATION; DNMT1 GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOID CELL; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SOUTHERN BLOTTING;

CELL TRANSFORMATION, NEOPLASTIC; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MYOD PROTEIN;

EID: 0036870174     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Baylin SB, Herman JG, Graff JR, Vertino PM and Issa JP: Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196, 1998.
2. Braun T, Bober E, Buschhausen-Denkr G, Kotz S, Grzeschik KH and Arnold HH: Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products. EMBO J 8: 3617-3625, 1989.
3. Taylor JME, Kay PH and Spagnolo DV: The diagnostic significance of Myf-3 hypermethylation in malignant lymphoproliferative disorders. Leukemia 15: 583-589, 2001.
4. Hahnel R, Harvey J and Kay PH: Hypermethylation of the myogenic gene Myf-3 in human breast carcinomas. Anticancer Res 16: 2111-2116, 1996.
5. Iacopetta BJ, Harmon D, Spagnolo DV, House AK and Kay PH: Hypermethylation of the Myf-3 gene in human colorectal cancer. Anticancer Res 16: 1-6, 1996.
6. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D: 5'CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1: 686-692, 1995.
7. Cooper DN and Youssoufian M: The CpG dinucleotide and human genetic disease. Hum Genet 78: 151-155, 1988.
8. Jones PA, Wolkowicz MJ, Rideout WM, Gonzales FA, Marziasz CM, Coetzee GA and Tapscott SJ: De novo methylation of the MyoDI CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci USA 87: 6117-6121, 1990.
9. Bestor T, Laudano A, Matttaliano R and Ingram V: Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal deomain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol 203: 971-983, 1988.
10. Bagwe AN, Ahmed MO, Franchina M, Spagnolo DV, Papadimitriou JM and Kay PH: A novel MspI PCR-RFLP in the human cytosine 5-methyltransferase gene: Lack of relevance for malignant lymphoproliferative disease and breast cancer. Hum Hered 48: 226-229, 1998.
11. Franchina M and Kay PH: Allele-specific variation in the gene copy number of human cytosine 5-methyltransferase. Hum Hered 50: 112-117, 2000.
12. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE and Jaenisch R: Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81: 197-205, 1995.